Marshall Wace
AXNX

Marshall Wace’s Axonics, Inc. Common Stock AXNX Stock Holding History

Marshall Wace’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-125,608
Closed -$8.74M – 3121
2024
Q3 		$8.74M Sell
125,608
-2,713
-2% -$186K 0.01% 801
2024
Q2 		$8.63M Sell
128,321
-29,589
-19% -$1.99M 0.01% 799
2024
Q1 		$10.9M Buy
+157,910
New +$10.7M 0.02% 719
2023
Q4 		– Sell
-152,686
Closed -$8.57M – 2696
2023
Q3 		$8.57M Sell
152,686
-725,279
-83% -$40.8M 0.02% 696
2023
Q2 		$44.3M Buy
877,965
+89,553
+11% +$4.76M 0.09% 245
2023
Q1 		$43M Buy
788,412
+162,277
+26% +$9.48M 0.09% 250
2022
Q4 		$39.2M Sell
626,135
-207,946
-25% -$13.8M 0.09% 252
2022
Q3 		$58.8M Buy
834,081
+319,388
+62% +$22M 0.13% 163
2022
Q2 		$29.2M Sell
514,693
-507,339
-50% -$27.8M 0.06% 336
2022
Q1 		$64M Buy
1,022,032
+327,700
+47% +$17.7M 0.12% 175
2021
Q4 		$38.9M Buy
+694,332
New +$42.4M 0.07% 276

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Marshall Wace's AXNX Position: Q4 2024 in Review

Marshall Wace sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 125,608 shares — an estimated $8.74M sold.

Marshall Wace first reported a position in AXNX in Q4 2021 and held it in 11 quarters. The position peaked at $64M in Q1 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Marshall Wace reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Marshall Wace sold 125,608 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $8.74M.
  • Marshall Wace first reported a position in Axonics, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • Marshall Wace's Axonics, Inc. Common Stock position peaked at $64M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.